1. Rowland JH, Hewitt M, Ganz PA. Cancer survivorship: a new challenge in delivering quality cancer care. J Clin Oncol 2006;24:5101–4.

2. National Cancer Information Center. Cancer facts and figures 2015 in the Republic of Korea [Internet]. Goyang, National Cancer Center. 2015;[cited 2017 Sep 6]. Available from: http://www.ncc.re.kr. 4. Shin DW, Cho B, Kim SY, Jung JH, Park JH. Management of cancer survivors in clinical and public health perspectives: current status and future challenges in Korea. J Korean Med Sci 2013;28:651–7.

5. Travis LB. The epidemiology of second primary cancers. Cancer Epidemiol Biomarkers Prev 2006;15:2020–6.

6. Supramaniam R. New Malignancies Among Cancer Survivors: SEER Cancer Registries, 1973–2000. J Epidemiol Community Health 2008;62:375–376.

8. Kweon S, Kim Y, Jang MJ, Kim Y, Kim K, Choi S, et al. Data resource profile: the Korea National Health and Nutrition Examination Survey (KNHANES). Int J Epidemiol 2014;43:69–77.

9. Yoon SJ, Bae SC, Lee SI, Chang H, Jo HS, Sung JH, et al. Measuring the burden of disease in Korea. J Korean Med Sci 2007;22:518–23.

10. van Luijt PA, Heijnsdijk EA, de Koning HJ. Cost-effectiveness of the Norwegian breast cancer screening program. Int J Cancer 2017;140:833–40.

11. Chiu SY, Malila N, Yen AM, Chen SL, Fann JC, Hakama M. Predicting the effectiveness of the Finnish population-based colorectal cancer screening programme. J Med Screen 2017;24:182–8.

12. Shin DW, Kim YW, Oh JH, Kim SW, Chung KW, Lee WY, et al. Knowledge, attitudes, risk perception, and cancer screening behaviors among cancer survivors. Cancer 2011;117:3850–9.

13. Jung KW, Won YJ, Kong HJ, Lee ES; Community of Population-Based Regional Cancer Registries. cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2015. Cancer Res Treat 2018;50:303–16.

14. Ng AK, Travis LB. Subsequent malignant neoplasms in cancer survivors. Cancer J 2008;14:429–34.

15. Chen Y, Thompson W, Semenciw R, Mao Y. Epidemiology of contralateral breast cancer. Cancer Epidemiol Biomarkers Prev 1999;8:855–61.

16. Soerjomataram I, Louwman WJ, van der Sangen MJ, Roumen RM, Coebergh JW. Increased risk of second malignancies after in situ breast carcinoma in a population-based registry. Br J Cancer 2006;95:393–7.

17. Liu L, Lemmens VE, de Hingh IH, de Vries E, Roukema JA, van Leerdam ME, et al. Second primary cancers in subsites of colon and rectum in patients with previous colorectal cancer. Dis Colon Rectum 2013;56:158–68.

18. Cho J, Guallar E, Hsu YJ, Shin DW, Lee WC. A comparison of cancer screening practices in cancer survivors and in the general population: the Korean national health and nutrition examination survey (KNHANES) 2001-2007. Cancer Causes Control 2010;21:2203–12.

19. Schumacher JR, Witt WP, Palta M, LoConte NK, Heidrich SM, Trentham-Dietz A, et al. After surviving a cancer diagnosis, do patients receive increased cancer screening? J Am Board of Fam Med 2012;25:460.

20. Grunfeld E, Moineddin R, Gunraj N, Del Giudice ME, Hodgson DC, Kwon JS, et al. Cancer screening practices of cancer survivors: population-based, longitudinal study. Can Fam Physician 2012;58:980–6.

21. Lee YY, Jun JK, Suh M, Park BY, Kim Y, Choi KS. Barriers to cancer screening among medical aid program recipients in the Republic of Korea: a qualitative study. Asian Pac J Cancer Prev 2014;15:589–94.